| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Garofalo Elizabeth A. is a Director at ALEC with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $909K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | ACAD Acadia Pharmaceuticals Inc | Director | Sell | 1,600 | $25.98 | $41,560.48 | -5.9% | -3.3% | - | |
| Mar 5, 2025 | ACAD Acadia Pharmaceuticals Inc | Director | Sell | 4,919 | $18.23 | $89,673.37 | -21.8% | +21.6% | +23.9% | |
| Mar 8, 2024 | XENE Xenon Pharmaceuticals Inc. | Director | Sale+OE | 2,092 | $45.69 | $95,583.48 | -100% | -18.2% | -21.1% |